Início › Linfoma de Burkitt › Delaware

Ensaios clínicos de Linfoma de Burkitt em Delaware

7 estudos para Linfoma de Burkitt estão buscando participantes em locais em Delaware.

Texto oficial do estudo (Inglês)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Alfred I duPont Hospital for Children, Wilmington

RecrutandoFase 2

366 Days – 46 Years · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06124157

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Alfred I duPont Hospital for Children, Wilmington

RecrutandoFase 2

365 Days · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Alfred I duPont Hospital for Children, Wilmington

RecrutandoFase 2

Idades de 1 a 30 · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Alfred I duPont Hospital for Children, Wilmington

RecrutandoFase 3

365 Days – 25 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

Christiana Care Hospital - Helen F Graham Cancer Center, Newark

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington

RecrutandoFase 2

Idades de 1 a 25 · Todos os sexos · Atualizado em 4 de mai. de 2025 · NCT03509961

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.